File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Serum anti-müllerian hormone level is not altered in women using hormonal contraceptives

TitleSerum anti-müllerian hormone level is not altered in women using hormonal contraceptives
Authors
Issue Date2011
PublisherElsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/contraception
Citation
Contraception, 2011, v. 83 n. 6, p. 582-585 How to Cite?
AbstractBackground: Anti-müllerian hormone (AMH) is secreted from granulosa cells of antral follicles into the circulation of adult women and hence could serve as an ovarian function test. This would be of value to hormonal contraceptive users if its serum level is unaffected by the use of hormonal contraceptives. Study Design: We prospectively recruited 95 women using combined oral contraceptive (n=23), combined injectable contraceptive (n=23), progestogen-only pills (n=9), progestogen-only injectable (n=20) and levonorgestrel intrauterine system (n=20), and measured their serum AMH concentration before and 3-4 months after treatment. Results: No significant difference in pre- and post-treatment serum AMH level was evident in all the treatment groups studied. Conclusions: Being unaffected by hormonal contraceptives, serum AMH measurement is potentially a useful clinical test in hormonal contraceptive users for the differential diagnosis of anovulatory disorders and determination of menopause. © 2011 Elsevier Inc. All rights reserved.
Persistent Identifierhttp://hdl.handle.net/10722/167093
ISSN
2015 Impact Factor: 2.788
2015 SCImago Journal Rankings: 1.557
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorLi, HWRen_US
dc.contributor.authorWong, CYGen_US
dc.contributor.authorYeung, WSBen_US
dc.contributor.authorHo, PCen_US
dc.contributor.authorNg, EHYen_US
dc.date.accessioned2012-09-28T04:03:39Z-
dc.date.available2012-09-28T04:03:39Z-
dc.date.issued2011en_US
dc.identifier.citationContraception, 2011, v. 83 n. 6, p. 582-585en_US
dc.identifier.issn0010-7824en_US
dc.identifier.urihttp://hdl.handle.net/10722/167093-
dc.description.abstractBackground: Anti-müllerian hormone (AMH) is secreted from granulosa cells of antral follicles into the circulation of adult women and hence could serve as an ovarian function test. This would be of value to hormonal contraceptive users if its serum level is unaffected by the use of hormonal contraceptives. Study Design: We prospectively recruited 95 women using combined oral contraceptive (n=23), combined injectable contraceptive (n=23), progestogen-only pills (n=9), progestogen-only injectable (n=20) and levonorgestrel intrauterine system (n=20), and measured their serum AMH concentration before and 3-4 months after treatment. Results: No significant difference in pre- and post-treatment serum AMH level was evident in all the treatment groups studied. Conclusions: Being unaffected by hormonal contraceptives, serum AMH measurement is potentially a useful clinical test in hormonal contraceptive users for the differential diagnosis of anovulatory disorders and determination of menopause. © 2011 Elsevier Inc. All rights reserved.en_US
dc.languageengen_US
dc.publisherElsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/contraceptionen_US
dc.relation.ispartofContraceptionen_US
dc.subject.meshAdulten_US
dc.subject.meshAnti-Mullerian Hormone - Blooden_US
dc.subject.meshBiological Markers - Blooden_US
dc.subject.meshContraceptives, Oral, Combined - Pharmacologyen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshIntrauterine Devices, Medicateden_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshProgestins - Pharmacologyen_US
dc.subject.meshProspective Studiesen_US
dc.titleSerum anti-müllerian hormone level is not altered in women using hormonal contraceptivesen_US
dc.typeArticleen_US
dc.identifier.emailLi, HWR: raymondli@hku.hken_US
dc.identifier.emailYeung, WSB: wsbyeung@hkucc.hku.hken_US
dc.identifier.emailHo, PC: pcho@hku.hken_US
dc.identifier.emailNg, EHY: nghye@hku.hken_US
dc.identifier.authorityLi, HWR=rp01649en_US
dc.identifier.authorityYeung, WSB=rp00331en_US
dc.identifier.authorityHo, PC=rp00325en_US
dc.identifier.authorityNg, EHY=rp00426en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1016/j.contraception.2010.09.007en_US
dc.identifier.pmid21570558-
dc.identifier.scopuseid_2-s2.0-79955937881en_US
dc.identifier.hkuros187021-
dc.identifier.hkuros221700-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-79955937881&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume83en_US
dc.identifier.issue6en_US
dc.identifier.spage582en_US
dc.identifier.epage585en_US
dc.identifier.isiWOS:000291176800015-
dc.publisher.placeUnited Statesen_US
dc.identifier.scopusauthoridLi, HWR=8554164300en_US
dc.identifier.scopusauthoridWong, CYG=9234680400en_US
dc.identifier.scopusauthoridYeung, WSB=7102370745en_US
dc.identifier.scopusauthoridHo, PC=7402211440en_US
dc.identifier.scopusauthoridNg, EHY=35238184300en_US
dc.identifier.citeulike8133833-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats